Secretive AI drug hunter Xaira dips toe into dealmaking with hunt for partners

A mostly black box since emerging with more than a billion dollars in hand, Xaira Therapeutics is slowly pulling back the curtain, revealing plans to find partners and validate its pipeline.

Scroll to Top